Current Good Manufacturing

Ranbaxy was hit with another import alert from the FDA on Monday.

Update

US FDA punishes Ranbaxy again with another import alert

By Zachary Brennan

After finding cGMP violations at another Ranbaxy plant in India, the US FDA on Monday issued an import alert that effectively stops all of the plant’s drug shipments from entering the US.

FDA planning GMP revamp

FDA planning GMP revamp

The US Food and Drug Administration is gearing up for the first
major overhaul of its current Good Manufacturing Practice
guidelines in 25 years, according to the agency's Commissioner Mark
McClellan. The move is just one strand...